Study on Cardiovascular Health, Nutrition and Physical Functioning in Older Adults in Spain (Sen-ENRICAII)

December 14, 2023 updated by: Fernando Rodríguez-Artalejo, Universidad Autonoma de Madrid

Study on Cardiovascular Health, Nutrition and Physical Functioning in Older Adults in Spain (Seniors-ENRICA II)

Population aging makes it necessary to identify factors related to unhealthy aging. The purpose of this study is to examine the association between ideal cardiovascular health, diet and other lifestyles and biological risk factors (either clasical or emergent) and the risk of physical and cognitive function impairment and mortality in a cohort of community-living individuals aged 65 years and over.

Study Overview

Status

Enrolling by invitation

Study Type

Observational

Enrollment (Estimated)

4000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Madrid, Spain, 28029
        • Department of Preventive Medicine and Public Health. Universidad Autonoma de Madrid

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Community-living individuals in the region of Madrid, Spain, aged 65 years or older.

Description

Inclusion Criteria:

  • Non-institutionalized residents in the region of Madrid, Spain.
  • 65 years and over

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional limitations on bicep-femoral flexibility
Time Frame: 3 years
Chair Sit and Reach test
3 years
Functional limitations on shoulder flexibility
Time Frame: 3 years
Back Scratch test
3 years
Functional limitations on balance
Time Frame: 3 years
Short Physical Performance Battery (SPPB): Balance test
3 years
Functional limitations on gait speed
Time Frame: 3 years
Short Physical Performance Battery (SPPB): Gait Speed test
3 years
Functional limitations on strength of legs
Time Frame: 3 years
Short Physical Performance Battery (SPPB): Chair Stand test
3 years
Functional limitations on strength of hands
Time Frame: 3 years
Hydraulic hand dynamometer (Jamar Plus +)
3 years
Functional limitations on activities of daily living
Time Frame: 3 years
Activities of Daily Living (ADLs) test
3 years
Functional limitations on instrumental activities of daily living
Time Frame: 3 years
Instrumental Activities of Daily Living (IADLs) test
3 years
Functional limitations on olfactory function
Time Frame: 3 years
Pocket Smell test
3 years
Functional limitations on taste function
Time Frame: 3 years
NIH Tool Box Taste test
3 years
Functional limitations on auditory function
Time Frame: 3 years
Audiometry
3 years
Cognitive impairment
Time Frame: 3 years
Mini-Mental State Examination (MMSE)
3 years
Executive function limitations on working memory
Time Frame: 3 years
Digits Forward test (WAIS-III),
3 years
Executive function limitations on programmed motor tasks
Time Frame: 3 years
Three Hand Position test of Luria
3 years
Executive function limitations on motor response control
Time Frame: 3 years
GO-NO-GO test.
3 years
Memory function limitations
Time Frame: 3 years
Seven Minute Screen (orientation, memory, clock drawing, verbal fluency)
3 years
Frailty
Time Frame: 3 years
Fried criteria
3 years
Falls
Time Frame: 3 years

From the question:

"How many times have you fallen down since the last interview? a) Number of falls; b) Number of injurious falls; c) Number of falls with fracture

3 years
Arterial stiffness estimated by pulse wave velocity (PWV)
Time Frame: 3 years
Ambulatory Blood Pressure Monitor using the oscillometric method (Mobil-O-Graph PWA) to estimate PWV (m/s) over a 24 hours period
3 years
Arterial stiffness estimated by central sistolic blood pressure (CSBP)
Time Frame: 3 years
Ambulatory Blood Pressure Monitor using the oscillometric method (Mobil-O-Graph PWA) to estimate CSBP (mmHg) over a 24 hours period
3 years
Arterial stiffness estimated by augmentation index (AI)
Time Frame: 3 years
Ambulatory Blood Pressure Monitor using the oscillometric method (Mobil-O-Graph PWA) to estimate AI (%) over a 24 hours period
3 years
24-h systolic and diastolic blood pressure
Time Frame: 3 years
Ambulatory Blood Pressure Monitor using the oscillometric method (Mobil-O-Graph PWA) to estimate brachial blood pressure (systolic and diastolic) (mmHg) over a 24 hours period
3 years
Mortality
Time Frame: 3 years
From the National Institute of Statistics of Spain
3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Fernando Rodríguez-Artalejo, MD, PhD, Department of Preventive Medicine and Public Health. Universidad Autonoma de Madrid
  • Principal Investigator: Jose R Banegas, MD, PhD, Department of Preventive Medicine and Public Health. Universidad Autonoma de Madrid

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2016

Primary Completion (Actual)

September 1, 2018

Study Completion (Estimated)

September 1, 2030

Study Registration Dates

First Submitted

March 20, 2018

First Submitted That Met QC Criteria

May 17, 2018

First Posted (Actual)

May 30, 2018

Study Record Updates

Last Update Posted (Actual)

December 20, 2023

Last Update Submitted That Met QC Criteria

December 14, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe